Petra Seidel
A15, Science Rd
Sydney, NSW 2006, Australia
Sydney, NSW 2006, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The MNK-1/eIF4E pathway as a new therapeutic pathway to target inflammation and remodelling in asthma.
Journal: Cellular signalling
Published: March 29, 2016
Corticosteroids inhibit sphingosine 1-phosphate-induced interleukin-6 secretion from human airway smooth muscle via mitogen-activated protein kinase phosphatase 1-mediated repression of mitogen and stress-activated protein kinase 1.
Journal: American journal of respiratory cell and molecular biology
Published: September 17, 2013
Anti-inflammatory dimethylfumarate: a potential new therapy for asthma?
Journal: Mediators of inflammation
Published: December 11, 2012
Dimethylfumarate inhibits CXCL10 via haem oxygenase-1 in airway smooth muscle.
Journal: The European respiratory journal
Published: July 14, 2012
Thiazolidinediones inhibit airway smooth muscle release of the chemokine CXCL10: in vitro comparison with current asthma therapies.
Journal: Respiratory research
Published: March 26, 2012
Corticosteroids and β₂-agonists upregulate mitogen-activated protein kinase phosphatase 1: in vitro mechanisms.
Journal: British journal of pharmacology
Published: March 01, 2012
TLR2 ligand engagement upregulates airway smooth muscle TNFα-induced cytokine production.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: January 17, 2012
MKP-1: a negative feedback effector that represses MAPK-mediated pro-inflammatory signaling pathways and cytokine secretion in human airway smooth muscle cells.
Journal: Cellular signalling
Published: November 11, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026